Literature DB >> 8522332

Germline mosaicism for an alanine to valine substitution at residue beta 140 in hemoglobin Puttelange, a new variant with high oxygen affinity.

H Wajcman1, E Girodon, D Promé, M L North, F Plassa, I Duwig, J Kister, J P Bergerat, F Oberling, E Lampert.   

Abstract

Hb Puttelange [beta 140(H18)Ala-->Val] was found as a de novo mutation in two siblings of a French family suffering from polycythemia. Both parents were phenotypically normal and exclusion of paternity has been ruled out by the study of several polymorphic markers located on different chromosomes. The structural modification of Hb Puttelange was established by reversed-phase HPLC analysis of the tryptic digest of the abnormal chain. The amino acid composition of an abnormal beta T14 peptide revealed that one of the four residues of Ala was replaced by a Val. Tandem mass spectrometry demonstrated that the substitution concerned position beta 140 (H18). This hemoglobin displays an increased oxygen affinity that is responsible for the polycythemia. De novo mutations, as demonstrated again in the case of this variant, have the highest probabilities of detection when they lead to pathological manifestations. They may result either from a somatic mutation in a very early stage of the embryological development of the propositus or may have a parental origin with occurrence of a germline mosaicism. The study of the beta-globin gene indicated that this case of Hb Puttelange probably arose from a mutation affecting a part of the germline of the father, therefore leading to a true recurrence risk.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8522332     DOI: 10.1007/bf00210304

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

Review 1.  Cases of abnormal human hemoglobin produced by de novo mutation.

Authors:  P E Nute; G Stamatoyannopoulos
Journal:  Hemoglobin       Date:  1988       Impact factor: 0.849

Review 2.  Review and hypotheses: somatic mosaicism: observations related to clinical genetics.

Authors:  J G Hall
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

3.  Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus.

Authors:  U B Gyllensten; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

4.  Detection and localization of single base changes by denaturing gradient gel electrophoresis.

Authors:  R M Myers; T Maniatis; L S Lerman
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  Characterization approach of 'silent' beta-chain hemoglobin variants.

Authors:  C Lacombe; J Riou; C Godard; J Rosa; F Galacteros
Journal:  Acta Haematol       Date:  1987       Impact factor: 2.195

6.  Structural characterization of abnormal hemoglobins from dried blood specimens in a neonatal screening program.

Authors:  H Wajcman; J Bardakdjian; R Ducrocq
Journal:  Ann Biol Clin (Paris)       Date:  1993       Impact factor: 0.459

7.  Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster.

Authors:  S H Orkin; H H Kazazian; S E Antonarakis; S C Goff; C D Boehm; J P Sexton; P G Waber; P J Giardina
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

8.  An expanded two-state allosteric model for interactions of human hemoglobin A with nonsaturating concentrations of 2,3-diphosphoglycerate.

Authors:  J Kister; C Poyart; S J Edelstein
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

9.  Structure and function of Hb Saint-Jacques (alpha 2 beta 2 140 (H18) Ala----Thr): a new high-oxygen-affinity variant with altered bisphosphoglycerate binding.

Authors:  J Rochette; B Varet; J P Boissel; K Clough; D Labie; H Wajcman; B Bohn; P Magne; C Poyart
Journal:  Biochim Biophys Acta       Date:  1984-02-28

10.  Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome.

Authors:  S Amselem; P Duquesnoy; B Duriez; F Dastot; M L Sobrier; S Valleix; M Goossens
Journal:  Hum Mol Genet       Date:  1993-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.